Report Code : CVMI24071650 | Published Date : July 16, 2024
The Oncology Nutrition Market is experiencing robust growth, fueled by the rising prevalence of cancer, a greater adoption of specialized cancer diets, and advancements in nutrition-based supportive therapies. Valued at USD XX billion in 2023, it is projected to expand at a CAGR of XX% from 2024 to 2031, reaching USD XX billion by 2031.
Oncology Nutrition Market Key Market Insights
Oncology nutrition emphasizes personalized dietary solutions for cancer patients, including immune-boosting meal plans, high-protein formulations, and plant-based diets that support cancer treatment. Integrating clinical nutrition into cancer care is enhancing patient recovery and treatment outcomes outcomes.
Oncology Nutrition Market Growth Drivers
- Rising Cancer Incidence and the Need for Nutrition-Based Therapies – The increasing number of cancer cases is driving the demand for therapeutic diets and nutrition supplements.
- Advancements in Personalized Oncology Nutrition Plans – The development of customized meal replacements and precision-targeted dietary guidelines is enhancing support for cancer treatment
- Expanding the Use of Functional Foods and Nutraceuticals in Cancer Care – The demand for diets rich in antioxidants, immune-enhancing properties, and anti-inflammatory benefits is growing.
- Government and Healthcare Initiatives Promoting Oncology Nutrition – Organizations are advocating for nutrition-based cancer treatment protocols.
Oncology Nutrition Market Regional Trends
- North America leads due to a high adoption of cancer-supportive nutrition and robust research in diet-based oncology care.
- Europe is expanding its government-backed cancer nutrition initiatives programs.
- Asia-Pacific is experiencing rapid growth due to heightened cancer awareness and improved healthcare spending.
- Latin America and the MEA region are emerging markets that are benefiting from nutrition-based cancer treatments integration.
ClearView Market Insights Analysis
The Oncology Nutrition Market is set for continuous expansion, driven by advancements in clinical nutrition, personalized dietary solutions, and growing acceptance of functional cancer-supportive foods. Companies investing in precision-based meal planning, AI-driven oncology diet tracking, and research in plant-based cancer nutrition will dominate this evolving sector.
Reasons To Buy
nan
Scope
nan
Key Players
- Abbott Laboratories
- Nestlé Health Science
- Danone S.A.
- Fresenius Kabi AG
- B. Braun Melsungen AG
Global Oncology Nutrition Market Report
- 1. Global Oncology Nutrition Market Research Report
- 1.1 Study Objectives
- 1.2 Global Oncology Nutrition Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Oncology Nutrition Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Type of Cancer
- 2.1.2 By Nutritional Products
- 2.1.3 By Stage of Cancer
- 2.1.4 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Type of Cancer, By Nutritional Products, By Stage of Cancer, By Country
- 3.3. Opportunities – By Type of Cancer, By Nutritional Products, By Stage of Cancer, By Country
- 3.4. Trends – By Type of Cancer, By Nutritional Products, By Stage of Cancer, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Oncology Nutrition Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Breast Cancer
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Lung Cancer
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Colorectal Cancer
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.4 Prostate Cancer
- 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.5 Ovarian Cancer
- 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.6 Pancreatic Cancer
- 5.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.7 Others
- 5.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Enteral Nutrition (Standard and Disease-Specific Formulas)
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Parenteral Nutrition (Amino Acids
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Lipids
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.4 Carbohydrates)
- 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.5 Oral Nutritional Supplements (Protein Supplements
- 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.6 High-Calorie Drinks)
- 6.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.7 Medical Foods (Nutritionally Complete Foods for Cancer Patients)
- 6.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Early-Stage Cancer
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Advanced-Stage Cancer
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Europe
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Asia-Pacific
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Latin America
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5 Middle East & Africa
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.6 Global Oncology Nutrition Market - Opportunity Analysis Index, By Type of Cancer, By Nutritional Products, By Stage of Cancer, and Region, 2024 - 2031
- 9.1 By Type of Cancer Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Breast Cancer
- 9.1.2 Lung Cancer
- 9.1.3 Colorectal Cancer
- 9.1.4 Prostate Cancer
- 9.1.5 Ovarian Cancer
- 9.1.6 Pancreatic Cancer
- 9.1.7 Others
- 9.2.1 Enteral Nutrition (Standard and Disease-Specific Formulas)
- 9.2.2 Parenteral Nutrition (Amino Acids
- 9.2.3 Lipids
- 9.2.4 Carbohydrates)
- 9.2.5 Oral Nutritional Supplements (Protein Supplements
- 9.2.6 High-Calorie Drinks)
- 9.2.7 Medical Foods (Nutritionally Complete Foods for Cancer Patients)
- 9.3.1 Early-Stage Cancer
- 9.3.2 Advanced-Stage Cancer
- 9.4.1 United States
- 9.4.2 Canada
9.6 Regional Trends Analysis
9.7 North America Global Oncology Nutrition Market Research Report - Company Profiles- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Type of Cancer Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Breast Cancer
- 10.1.2 Lung Cancer
- 10.1.3 Colorectal Cancer
- 10.1.4 Prostate Cancer
- 10.1.5 Ovarian Cancer
- 10.1.6 Pancreatic Cancer
- 10.1.7 Others
- 10.2.1 Enteral Nutrition (Standard and Disease-Specific Formulas)
- 10.2.2 Parenteral Nutrition (Amino Acids
- 10.2.3 Lipids
- 10.2.4 Carbohydrates)
- 10.2.5 Oral Nutritional Supplements (Protein Supplements
- 10.2.6 High-Calorie Drinks)
- 10.2.7 Medical Foods (Nutritionally Complete Foods for Cancer Patients)
- 10.3.1 Early-Stage Cancer
- 10.3.2 Advanced-Stage Cancer
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands
- 10.4.8 Poland
- 10.4.9 Rest of Europe
10.6 Regional Trends Analysis
10.7 Europe Global Oncology Nutrition Market Research Report - Company Profiles- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Type of Cancer Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Breast Cancer
- 11.1.2 Lung Cancer
- 11.1.3 Colorectal Cancer
- 11.1.4 Prostate Cancer
- 11.1.5 Ovarian Cancer
- 11.1.6 Pancreatic Cancer
- 11.1.7 Others
- 11.2.1 Enteral Nutrition (Standard and Disease-Specific Formulas)
- 11.2.2 Parenteral Nutrition (Amino Acids
- 11.2.3 Lipids
- 11.2.4 Carbohydrates)
- 11.2.5 Oral Nutritional Supplements (Protein Supplements
- 11.2.6 High-Calorie Drinks)
- 11.2.7 Medical Foods (Nutritionally Complete Foods for Cancer Patients)
- 11.3.1 Early-Stage Cancer
- 11.3.2 Advanced-Stage Cancer
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & NZ
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Oncology Nutrition Market Research Report - Company Profiles- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Type of Cancer Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Breast Cancer
- 12.1.2 Lung Cancer
- 12.1.3 Colorectal Cancer
- 12.1.4 Prostate Cancer
- 12.1.5 Ovarian Cancer
- 12.1.6 Pancreatic Cancer
- 12.1.7 Others
- 12.2.1 Enteral Nutrition (Standard and Disease-Specific Formulas)
- 12.2.2 Parenteral Nutrition (Amino Acids
- 12.2.3 Lipids
- 12.2.4 Carbohydrates)
- 12.2.5 Oral Nutritional Supplements (Protein Supplements
- 12.2.6 High-Calorie Drinks)
- 12.2.7 Medical Foods (Nutritionally Complete Foods for Cancer Patients)
- 12.3.1 Early-Stage Cancer
- 12.3.2 Advanced-Stage Cancer
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
12.6 Regional Trends Analysis
12.7 Latin America Global Oncology Nutrition Market Research Report - Company Profiles- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Type of Cancer Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Breast Cancer
- 13.1.2 Lung Cancer
- 13.1.3 Colorectal Cancer
- 13.1.4 Prostate Cancer
- 13.1.5 Ovarian Cancer
- 13.1.6 Pancreatic Cancer
- 13.1.7 Others
- 13.2.1 Enteral Nutrition (Standard and Disease-Specific Formulas)
- 13.2.2 Parenteral Nutrition (Amino Acids
- 13.2.3 Lipids
- 13.2.4 Carbohydrates)
- 13.2.5 Oral Nutritional Supplements (Protein Supplements
- 13.2.6 High-Calorie Drinks)
- 13.2.7 Medical Foods (Nutritionally Complete Foods for Cancer Patients)
- 13.3.1 Early-Stage Cancer
- 13.3.2 Advanced-Stage Cancer
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Oncology Nutrition Market Research Report - Company Profiles- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 14.2.1 Abbott Laboratories
- 14.2.2 Nestlé Health Science
- 14.2.3 Danone S.A.
- 14.2.4 Fresenius Kabi AG
- 14.2.5 B. Braun Melsungen AG
16. Principal Presumptions and Acronyms